| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |